PMID: 11328281May 1, 2001Paper

Decreased expression of transcription factor GATA-2 in haematopoietic stem cells in patients with aplastic anaemia

British Journal of Haematology
S FujimakiM Kaku

Abstract

Aplastic anaemia is characterized by reduced haematopoiesis resulting in pancytopenia. It has been speculated that there is an injury in haematopoietic stem cells in the bone marrow; however, the precise nature of the injury has not been elucidated. In this study, the levels of expression of mRNAs for three transcription factors, GATA-2, SCL and AML1, which function in the early stages of haematopoiesis, were examined by quantitative polymerase chain reaction in patients with aplastic anaemia, idiopathic thrombocytopenic purpura (ITP) and normal subjects. Among these factors, expression of GATA-2 mRNA in purified CD34-positive cells was markedly decreased in aplastic anaemia compared with that in ITP and in normal subjects. The expression levels of SCL and AML1 mRNA in CD34-positive cells in aplastic anaemia were not different from those in normal subjects. When the expression of GATA-2 protein in CD34-positive cells was examined by immunocytochemical analysis, the percentage of GATA-2-positive cells in aplastic anaemia was lower than that in normal subjects. These findings strongly suggest that there is an aberrant expression of transcription factors in stem cells in aplastic anaemia, which may be responsible for the developme...Continue Reading

References

May 8, 1997·The New England Journal of Medicine·N S Young, J Maciejewski
Jul 14, 1998·Blood Reviews·T Baglin
Jul 28, 1999·JAMA : the Journal of the American Medical Association·N S Young
Sep 15, 1999·European Journal of Haematology·N Novitzky, P Jacobs

❮ Previous
Next ❯

Citations

Jun 28, 2005·Leukemia Research·Shinichiro TakahashiMitsuo Kaku
Oct 7, 2004·The Journal of Experimental Medicine·Kam-Wing LingElaine Dzierzak
Jul 27, 2006·International Journal of Hematology·Hideo HarigaeTakeshi Sasaki
Sep 9, 2006·The Tohoku Journal of Experimental Medicine·Hideo Harigae
May 25, 2011·Critical Reviews in Oncology/hematology·Carmen VicenteMaría D Odero
Jan 5, 2010·Critical Reviews in Oncology/hematology·Jian Ping LiZhong Chao Han
May 28, 2010·Journal of Cellular Biochemistry·Angelina FeliciDonald P Bottaro
Oct 24, 2007·Biochemical and Biophysical Research Communications·Yoko OkitsuHideo Harigae
Feb 17, 2015·Clinical and Experimental Immunology·Y Zeng, E Katsanis
Sep 10, 2011·Blood·Anna Rita Migliaccio, James J Bieker
Jun 2, 2017·The Tohoku Journal of Experimental Medicine·Tohru Fujiwara
Aug 23, 2005·Expert Review of Anticancer Therapy·Edgardo S SantosRakesh Singal
Oct 29, 2003·Cytometry. Part B, Clinical Cytometry·Toshihiko MiuraHideo Harigae
Jul 13, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Cong LiuJeffrey A Whitsett
May 29, 2002·Oncogene·Jiang Zhu, Stephen G Emerson
Aug 12, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Cong LiuJeffrey A Whitsett
Dec 14, 2018·Frontiers in Endocrinology·Huifang WangYuping Gong
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mingzhou GuoMalcolm V Brock
Jan 26, 2021·Biochemistry and Biophysics Reports·Sarmistha AdhikariParamita Mandal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.